Best Prefered Companies To Buy Right Now

Exterran Holdings (NYSE: EXH  ) is expected to report Q1 earnings on May 2. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Exterran Holdings's revenues will grow 21.6% and EPS will turn positive

The average estimate for revenue is $761.9 million. On the bottom line, the average EPS estimate is $0.03.

Revenue details
Last quarter, Exterran Holdings reported revenue of $838.9 million. GAAP reported sales were 22% higher than the prior-year quarter's $689.1 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $0.09. GAAP EPS were -$0.09 for Q4 compared to -$1.06 per share for the prior-year quarter.

Top 5 Prefered Companies To Buy For 2015: Woodside Petroleum Ltd (WPL)

Woodside Petroleum Ltd (Woodside) is an Australia-based oil and gas company. Woodside, along with its subsidiaries is engaged in hydrocarbon exploration, evaluation, development, production and marketing. As of December 31, 2011, the Company produced around 700,000 barrels of oil equivalent each day from a portfolio of facilities, which it operates on behalf of some of the major oil and gas companies. It operating facilities include six liquefied natural gas (LNG) trains, five offshore platforms and four oil floating production storage and offloading (FPSO) vessels. It is one of the non-government operators LNG plants. The Company operates six segments: North West Shelf Business Unit, Australia Oil Business Unit, Pluto Business Unit, Browse Business Unit, United States Business Unit and Other. In September 2012, it sold a minority portion of its equity in the proposed Browse LNG Development to Japan Australia LNG (MIMI Browse) Pty Ltd. Advisors' Opinion:

• [By Jonathan Burgos]

  Agricultural Bank of China Ltd., the nation�� third-largest lender, slid 2.3 percent in Hong Kong. Yamada Denki Co. sank 4.8 percent in Tokyo after the consumer electronics retailer missed its full-year profit forecast. Woodside Petroleum Ltd. (WPL), Australia�� second-biggest oil producer, jumped 9.7 percent after announcing plans to return cash to shareholders.

• [By Adam Haigh]

  Energy producers advanced as crude oil prices rallied after the ousting of Egypt�� president fanned concern unrest will disrupt Middle East oil supply. Cnooc gained 2.1 percent to HK$12.80 in Hong Kong. China Petroleum & Chemical Corp., the nation�� largest refiner, rose 2.5 percent to HK$5.25. Woodside Petroleum Ltd. (WPL), Australia�� No. 2 energy producer, added 3 percent to A$35.64.

• [By Yoshiaki Nohara]

  Australia�� S&P/ASX 200 Index retreated 0.7 percent, led by energy and financial shares. Woodside Petroleum Ltd. (WPL), Australia�� second-biggest oil and gas producer, dropped 2 percent to A$34.67. Westpac Banking Corp. (WBC), Australia�� No. 2 lender by market value, shed 1.2 percent to A$27.47.

Best Prefered Companies To Buy Right Now: Hawkins Inc. (HWKN)

Hawkins, Inc. distributes bulk chemicals, as well as blends, manufactures, and distributes specialty chemicals. The company operates through two segments, Industrial and Water Treatment. The Industrial segment provides industrial chemicals, products, and services primarily to the agriculture, energy, electronics, food, chemical processing, pulp and paper, pharmaceutical, medical device, and plating industries. This segment primarily offers acids, alkalis, and industrial and food-grade salts; and receives, stores, and distributes various chemicals, including liquid caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. In addition, it manufactures sodium hypochlorite, agricultural products, and certain food-grade products comprising Cheese-Phos liquid phosphate, lactates, and other blended products; repackages water treatment and bulk industrial chemicals; and performs custom blending of certain chemicals, and contract and pr ivate label packaging for household chemicals. This segment primarily conducts its operations through distribution centers and terminal operations. The Water Treatment segment provides chemicals, equipment, and solutions for potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. Hawkins, Inc. was founded in 1938 and is based in Minneapolis, Minnesota.

Advisors' Opinion:

• [By Seth Jayson]

  Hawkins (Nasdaq: HWKN  ) reported earnings on May 29. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q4), Hawkins met expectations on revenues and beat expectations on earnings per share.

Best Prefered Companies To Buy Right Now: Titan Pharmaceuticals Inc (TTNP.OB)

Titan Pharmaceuticals, Inc., incorporated in February 1992, is a biopharmaceutical company developing therapeutics primarily for the treatment of central nervous system (CNS) disorders. The Company is focused primarily on clinical development of products that include Probuphine for the treatment of opioid addiction; Iloperidone: for the treatment of schizophrenia and related psychotic disorders, and Spheramine for the treatment of advanced Parkinson�� disease. Titan Pharmaceuticals is directly developing its product candidates and also utilizing corporate partnerships, including a collaboration with Bayer Schering Pharma AG, Germany (Bayer Schering) for the development of Spheramine to treat Parkinson�� disease, and Vanda Pharmaceuticals, Inc. (Vanda) for the development of iloperidone for the treatment of schizophrenia and related psychotic disorders.

Probuphine

Probuphine is the first product to utilize the Company�� ProNeura long-ter m drug delivery technology. Probuphine is designed to provide continuous, long-term therapeutic levels of the drug buprenorphine, an approved agent for the treatment of opioid addiction. In December 2007, the Company completed enrollment in a randomized, double-blind, placebo-controlled, multi-center Phase III clinical study of Probuphine in the treatment of opioid addiction. This 150 patient study, which is being conducted in the United States, will evaluate the safety and effectiveness of treatment with Probuphine versus placebo in reducing opioid addiction over 24 weeks of treatment. This study is part of a registration directed program intended to obtain marketing approval of Probuphine for the treatment of opioid addiction in Europe and the United States.

Iloperidone

Iloperidone was evaluated in a Phase III program comprising over 3,500 patients at more than 200 sites in 24 countries, administered and funded by Novartis Pharma AG (Novartis). In three completed efficacy studies conducted by Novartis, ! i! loperidone statistically reduced the symptoms of schizophrenia compared to placebo. Iloperidone has also been investigated in three 12-month safety studies, which confirm safety and tolerability. A dose dependent increase in the Q-T Corrected (QTc) interval was observed and investigated further in a clinical study, and no clinically significant adverse events were observed. In September 2007, Vanda submitted a new drug application (NDA) with the United States Food and Drug Administration (FDA) for iloperidone. The NDA for iloperidone was officially accepted for review by the FDA in November 2007.

Spheramine

Spheramine is a cell-based therapeutic that utilizes the Company�� cell-coated microcarrier (CCM) technology, which enables the development of cell-based therapies for minimally invasive, site-specific delivery to the central nervous system of therapeutic factors precisely where they are needed. Spheramine consists of microcarriers coated wit h human retinal pigment epithelial cells that are intended to enhance brain levels of dopamine, a neurotransmitter deficient in certain brain regions in Parkinson�� disease, leading to movement disorders. Preclinical studies have demonstrated the preliminary efficacy and safety of Spheramine, including blinded studies in a primate model of Parkinson�� disease. In June 2007, enrollment was completed in a current multi-center, randomized, double-blind, placebo-controlled clinical trial of Spheramine in Parkinson�� disease. This Phase IIb clinical study enrolled 71 patients with advanced Parkinson�� disease (Hoehn and Yahr Stages III and IV) to further evaluate the efficacy, safety, and tolerability of Spheramine.

Bayer Schering, the Company�� corporate partner for worldwide development and commercialization of Spheramine, is funding the clinical development program for Spheramine. Under an agreement, Bayer Schering has received exclusive, worldwide deve lopment, manufacturing and commercialization rights, an! d, in! ad! dition! to the clinical and manufacturing development funding and milestone payments, Bayer Schering will pay Titan Pharmaceuticals a royalty on future product sales.

Advisors' Opinion:

• [By C.R. Jackson]

  Fanapt was discovered by Hoechst Marion Roussel in 1995 as a novel atypical antipsychotic agent. Hoechst was a German life-sciences company that became Aventis Deutschland after its merger with France's Rhône-Poulenc in 1999. When the company joined with Sanofi-Synthélabo in 2004, it became a subsidiary of the Sanofi-Aventis (SNY) the French pharmaceutical conglomerate. In 1997, Hoechst sold the research rights to Titan Pharmaceuticals (TTNP.OB). Then Titan quickly sold the worldwide rights to Novartis in 1998. Novartis then sold the Phase 3 development rights for loperidone to Vanda in 2004. Vanda originally attempted to get FDA approval for Fanapt in 2008, but the FDA refused to approve iloperidone. The agency required an additional clinical trial.

Best Prefered Companies To Buy Right Now: R.R. Donnelley & Sons Company(RRD)

R.R. Donnelley & Sons Company provides pre-media, printing, logistics, and business process outsourcing products and services to private and public sectors worldwide. The company operates primarily in the commercial print portion of the printing industry, with related product and service offerings designed to offer customers solutions for communicating their messages to target audiences. Its products and related service offerings include magazines, catalogs, retail inserts, books, directories, financial print, direct mail, forms, labels, office products, statement printing, pre media, and logistics services. The company also offers business process outsourcing services that comprise transactional print and outsourcing services, statement printing, direct mail, and print management services; and product configuration, customized kitting, and order fulfillment for technology, medical device, and other companies. It distributes its products to end-users through the United Sta tes postal services, retail channels, electronically, or by direct shipment to customer facilities. R.R. Donnelley & Sons was founded in 1864 and is based in Chicago, Illinois.

Advisors' Opinion:

• [By Eric Volkman]

  RR Donnelley (NASDAQ: RRD  ) will pay a quarterly dividend of $0.26 per share of its common stock on June 3 to shareholders of record as of April 26, the company announced this week.

Best Prefered Companies To Buy Right Now: Astoria Financial Corp (AF)

Astoria Financial Corporation, incorporated on June, 14, 1993, is the unitary savings and loan association holding company of Astoria Federal Savings and Loan Association (Astoria Federal). The Company�� principal business is the operation of its wholly owned subsidiary, Astoria Federal. Astoria Federal�� primary business is attracting retail deposits from the general public and investing those deposits, together with funds generated from operations, principal repayments on loans and securities and borrowings, primarily in one- to four-family mortgage loans, multi-family mortgage loans, commercial real estate loans and mortgage-backed securities. Astoria Federal also invests in consumer and other loans, the United States Government, government agency and government-sponsored enterprise (GSE), securities and other investments.

Lending Activities

The Company�� loan portfolio consists primarily of mortgage loans. As of December 31, 2012, 74% of its total loan portfolio was secured by residential properties and 24% was secured by multi-family properties and commercial real estate. The remainder of the loan portfolio consists of a variety of consumer and other loans, including commercial and industrial loans originated in 2012 through its business banking initiatives. As of December 31, 2012, its net loan portfolio totaled $13.08 billion, or 79% of total assets. The Company originates mortgage loans either directly through its banking and loan production offices in New York or indirectly through brokers and its third party loan origination program. It also originates mortgage loans for sale. The Company�� primary lending focus is on the origination and purchase of first mortgage loans secured by one- to four-family properties that serve as the primary residence of the owner.

The Company also originates multi-family and commercial real estate loans. As of December 31, 2012, multi-family mortgage loans totaled $2.41 billion, or 18% of its total loan portfolio,! and commercial real estate loans totaled $773.9 million, or 6% of its total loan portfolio. At December 31, 2012, $264.1 million, or 2%, of the Company�� total loan portfolio consisted of consumer and other loans which were primarily home equity lines of credit. The Company also offers overdraft protection, lines of credit, commercial loans and passbook loans. Consumer and other loans, with the exception of home equity and commercial lines of credit, are offered primarily on a fixed rate, short-term basis.

Investment Activities

At December 31, 2012, the Company�� securities portfolio totaled $2.04 billion, or 12%, of total assets. The Company does not use derivatives for trading purposes. Its securities portfolio consists primarily of mortgage-backed securities. At December 31, 2012, its mortgage-backed securities totaled $1.94 billion, or 95%, of total securities, of which $1.92 billion, or 94%, of total securities, were real estate mortgage investment conduits (REMIC) and collateralized mortgage obligation (CMO) securities, substantially all of which had fixed rates. Of the REMIC and CMO securities portfolio, $2.35 billion, or 98.7%, are guaranteed by Federal National Mortgage Association (Fannie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac) or Government National Mortgage Association (Ginnie Mae) as issuer. At December 31, 2012, its securities available-for-sale totaled $336.3 million and its securities held-to-maturity totaled $1.7 billion. At December 31, 2012, it had no investments in repurchase agreements and federal funds sold.

Sources of Funds

The Company�� primary source of funds is the cash flow provided by its investing activities, including principal and interest payments on loans and securities. Its other sources of funds are provided by operating activities and financing activities, including deposits and borrowings. The Company offers a variety of deposit accounts with a range of interest rates and terms. It offers ! passbook ! and statement savings accounts, money market accounts, negotiable order of withdrawal (NOW) and demand deposit accounts, liquid certificates of deposit (Liquid CDs), and certificates of deposit, which include all time deposits other than Liquid CDs. Liquid CDs have maturities of three months, require the maintenance of a minimum balance and allow depositors the ability to make periodic deposits to and withdrawals from their account. At December 31, 2012, its deposits totaled $10.44 billion. Of the total deposit balance, $1.28 billion, or 12%, represented individual retirement accounts during the year ended December 31, 2012. It held no brokered deposits at December 31, 2012. Core deposits represented 53.3% of total deposits at December 31, 2011. Reverse repurchase agreements are accounted for as borrowings and are secured by the securities sold under the agreements. At December 31, 2012, borrowings totaled $4.37 billion. It also obtains advances from the Federal Home Loan Bank of New York (FHLB-NY).

Subsidiary Activities

In addition to Astoria Federal, the Company has two other subsidiaries, AF Insurance Agency, Inc. and Astoria Capital Trust I. AF Insurance Agency, Inc. is a life insurance agency. Through contractual agreements with various third parties, AF Insurance Agency, Inc. makes insurance products available primarily to the customers of Astoria Federal. Astoria Federal�� wholly owned subsidiaries include AF Agency, Inc., Astoria Federal Savings and Loan Association Revocable Grantor Trust, Astoria Federal Mortgage Corp. (AF Mortgage), Fidata Service Corp. (Fidata), Marcus I Inc. and Suffco Service Corporation (Suffco). AF Agency, Inc. makes various annuity products available to the customers of Astoria Federal through an unaffiliated third party vendor. AF Mortgage is an operating subsidiary through which Astoria Federal engages in lending activities outside the State of New York through its third party loan origination program. Fidata mortgage loans totaled $5.09 bi! llion at ! December 31, 2012. Suffco serves as document custodian for the loans of Astoria Federal and Fidata and certain loans being serviced for Fannie Mae and other investors.

Advisors' Opinion:

• [By Jonathan Morgan]

  Air France-KLM Group (AF), Europe�� second-biggest airline by sales, retreated 2.8 percent. Mediaset SpA climbed 2.8 percent after Credit Suisse Group AG raised its price target on the Italian broadcaster. Serco Group Plc added 2.7 percent after predicting that its revenue growth in the first half will exceed its previous estimates.

• [By Namitha Jagadeesh]

  International Consolidated Airlines Group SA (IAG) and Air France-KLM (AF) Group rose with as a gauge of travel stocks as oil prices fell after Iran�� accord. PSA Peugeot Citroen gained 3.7 percent after people familiar with the matter said its chief executive officer plans to step down next year. Fresenius Medical Care AG surged the most in five years after U.S. regulators scrapped a plan to cut Medicare payments next year.

Best Prefered Companies To Buy Right Now: Rex Energy Corporation(REXX)

Rex Energy Corporation operates as an independent oil and gas company in the Appalachian Basin and the Illinois Basin. It focuses on the Marcellus Shale drilling projects, and Utica Shale and Upper Devonian Shale exploration activities in the Appalachian Basin. The company also holds interests in the Lawrence Field ASP Flood project, which is an oil recovery project located in Lawrence County, Illinois. As of December 31, 2011, it operated approximately 2,117 wells, including approximately 517 disposal and injection wells. The company had estimated proved reserves of 366.2 billions of cubic feet equivalent. Rex Energy Corporation was founded in 2007 and is headquartered in State College, Pennsylvania.

Advisors' Opinion:

• [By Bret Jensen]

  Rex Energy Corporation (REXX) produces oil, natural gas, and natural gas liquids. The company focuses on the Marcellus Shale, Utica Shale, and Upper Devonian Shale.

• [By Garrett Cook]

  In trading on Monday, energy shares were relative leaders, up on the day by about 2.30 percent. Top losers in the sector included Petróleo Brasileiro S.A. (NYSE: PBR), down 14 percent, and Rex Energy (NASDAQ: REXX), off 9.8 percent.

• [By Matt DiLallo]

  These infrastructure additions are important for Gulfport Energy� (NASDAQ: GPOR  ) �which is pouring nearly all of its resources into developing the Utica's assets. If its wells provide the type of production it is expecting, this infrastructure build-out will prove critical to Gulfport's ability to deliver its product to market. The additions are also important for Rex Energy (NASDAQ: REXX  ) which is investing more than 30% of its more than $255 million 2013 capital budget to develop its acreage in the Utica.

• [By Arjun Sreekumar]

  Infrastructure additions also bode well for Gulfport Energy (NASDAQ: GPOR  ) , a company highly levered to the play. In fact, Gulfport is plowing the majority of its capital budget toward developing its Utica acreage, with quite impressive well results thus far. Improved infrastructure should also provide a boost to Rex Energy (NASDAQ: REXX  ) , which is allocating nearly a third of its roughly $255 million capital budget for the year toward developing its assets in the Utica.